We note that discussion of the surgical hierarchy for the proposed modifications is discussed in section II.C.15
Injectable When researchers study GHK-Cu, they usually do it one of two ways: topical or injectable
While these results are interesting to scientists, they are not proof of safety or effectiveness in humans
(PubMed) Graham DY, Anderson SY, Lang T
10.1002/acn3.186 [DOI] [PMC free article] [PubMed] [Google Scholar] Kitamura K., Fujiyoshi K., Yamane J., Toyota F., Hikishima K., Nomura T., et al
An illustrative example of using FCS in interactions of IDPs is given by a study published in 2000 by Pack et al., where the peculiarities of binding of disordered substrates (apo-cytochrome c and disulfide-reduced apo--lactalbumin) to GroEL was analyzed (Pack et al., 2000)